13th Dec 2021 22:04
Plant Health Care PLC - agriculture products firm based in North Carolina - Signs production and supply agreement with an unnamed European-based fermentation company to secure production capacity of PHC279, the active ingredient in the company's Saori soybean seed treatment. In addition, Plant Health Care has started pilot-scale manufacturing of other PREtec peptide in support of new product regulatory filings, which is expected to lead to commercial-scale manufacturing of a portfolio of PREtec-based products.
"We are delighted to have achieved this critical milestone in bringing our exciting new technology to market around the world. This new agreement establishes a first-class capability to supply Saori directly to our distribution partner in Brazil. Initial grower response to the launch of the Saori soybean seed treatment with Nutrien Ag Solutions in Brazil has been most encouraging and we are pleased to have established manufacturing arrangements to support wider adoption of PHC279 in 2022 and beyond," says Chief Executive Officer Chris Richards.
Current stock price: 10.00 pence, up 5.3% on Monday
Year-to-date change: down 25%
By Dayo Laniyan; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
PHC.L